Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Frailty in Heart Failure: Insights, Patient Outcomes & Future Directions
Author(s): Karol Mirkowski , Ercole Vellone , Bernadetta Żółkowska , et al Added: 1 year ago

Heart Failure
EPCs and Innovative Strategies for Endothelial Dysfunction in Heart Failure
Author(s): Eugenio Carulli , Marialuisa Sveva Marozzi , Maria Cristina Carella , et al Added: 8 months ago

Prevention & Chronic Conditions

Heart Failure
Job title: Clinical Electrophysiology Fellow
Rajiv Agarwal
Prof Rajiv Agarwal is an Emeritus Professor of Medicine at Indiana University School of Medicine in Indianapolis, US. He earned his medical degree from the All India Institute of Medical Sciences, New Delhi, India, and completed his nephrology fellowship at the University of Texas Southwestern in Dallas, US. He joined Indiana University in 1997, earning recognition such as the Trustee’s Teaching… View more
Apelin/APJ and Incretin Therapy in Heart Failure
Author(s): Dominic Marcel Alfonso Added: 2 months ago

MI/ACS

Heart Failure
Understanding the Role of GLP-1 RAs in the Treatment of HF
Author(s): Giovanni Battista Bonfioli , Matteo Pagnesi , Daniela Tomasoni , et al Added: 8 months ago

Cardiovascular Kidney Metabolic

Heart Failure
The Aldosterone Story: New Chapters
Author(s): Vijay Chopra Added: 9 months ago

Heart Failure
GLP-1RA in Different HFpEF Phenotypes
Author(s): Aleksandra Bykova , Maria Serova , Maria Chashkina , et al Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
VICTOR Trial: Vericiguat Shows No Benefit for Primary Endpoint in Stable HFrEF
Added: 8 months ago Source:  Radcliffe Cardiology
Results from the Phase III VICTOR trial, presented at the European Society of Cardiology (ESC) Congress 2025 and published in The Lancet, show that vericiguat did not meet its primary endpoint in patients with chronic, stable heart failure with reduced ejection fraction (HFrEF).¹˒²Vericiguat is an oral, once-daily stimulator of soluble guanylate cyclase (sGC), an enzyme in the nitric oxide… View more

Guidelines & Statements

Heart Failure
Biomarkers for Early Detection and Prognosis of Heart Failure
Author(s): Moza A Alzaabi , Amin Abdelsalam , Majid Alhammadi , et al Added: 1 year ago

Heart Failure